Jim Cramer told investors not to blame earnings reports for tame market action and focus on individual stocks instead. » Read More
Jim Cramer examined the recent spate of Chinese companies coming public on U.S. exchanges and explained why they're not worth buying. » Read More
By: Michelle Fox
Naming hedge-fund billionaire Nelson Peltz to the Procter & Gamble board will be beneficial to shareholders, CalSTRS' Anne Sheehan said. » Read More
A drop in Venezuela's critical energy imports has some analysts worried state oil giant PDVSA is struggling to fund its operations.
Traders make big bets on three key stocks ahead of earnings next week.
The full interview with David Abney.
Funds that track junk bonds saw $6.8 billion of outflows over the past week, third highest on record, according to Bank of America Merrill Lynch.
Shares of Foot Locker spiked 30 percent Friday after the shoe retailer posted stronger earnings, on track for its best day since 1977.
Investors are worried the angst over in-game monetization in EA's "Star Wars Battlefront II" will hurt its sales.
Evercore ISI upgrades shares of Square to outperform, citing the company's new lineup of payment technology and bitcoin prospects.
Coinbase said that there was still a possibility of a planned upgrade to bitcoin known as Segwit2x which appeared to spark the rally.
Jim Cramer gave kudos to the CEOs of Wal-Mart and Cisco for their turnaround stories after better-than-expected earnings reports.
There's one soaring chip maker that's about to make new highs.
While some may view General Electric stock as a no-touch at current levels, one strategist sees a buying opportunity.
Sweeping changes are coming to several key sectors in the S&P 500 next year, with big names like Amazon and Netflix likely being moved into a new sector.
Cisco shares surged to 16-year highs this week, but one strategist warns the rally is nothing more than a short squeeze.
A handful of stocks are trading at extreme levels, and a top technician says one name has even more room to run.
Mednax is a small Florida-based health-care services provider.
Goldman Sachs reiterates its buy rating for Intuitive Surgical shares, predicting the company will report earnings above expectations next year.
Get the best of CNBC in your inbox